This afternoon we watched Centene drop -8.1% to a price of $73.75 per share. The Large-Cap Medical Specialities company is now trading -14.19% below its average target price of $85.95. Analysts have set target prices ranging from $74.0 to $98.0 per share for Centene, and have given the stock an average rating of buy.
Centene's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.1%. The stock's short ratio is 2.28. The company's insiders own 0.27% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 101.0%. In conclusion, we believe there is mixed market sentiment regarding Centene.
Institutions Invested in Centene
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 12% | 60,717,252 | $4,477,897,335 |
| 2024-06-30 | Blackrock Inc. | 9% | 47,440,904 | $3,498,766,670 |
| 2024-06-30 | FMR, LLC | 7% | 35,080,211 | $2,587,165,561 |
| 2024-06-30 | Capital World Investors | 5% | 26,636,304 | $1,964,427,420 |
| 2024-06-30 | Harris Associates L.P. | 5% | 24,893,358 | $1,835,885,152 |
| 2024-06-30 | State Street Corporation | 4% | 23,356,505 | $1,722,542,243 |
| 2024-06-30 | Norges Bank Investment Management | 4% | 21,212,326 | $1,564,409,042 |
| 2024-06-30 | Wellington Management Group, LLP | 4% | 19,062,428 | $1,405,854,065 |
| 2024-06-30 | Geode Capital Management, LLC | 2% | 12,683,123 | $935,380,321 |
| 2024-06-30 | Politan Capital Management LP | 2% | 12,135,044 | $894,959,495 |
